Meeder Asset Management Inc Albireo Pharma, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$31.56 - $42.16 $86,190 - $115,138	-2,731 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$23.19 - $41.61 $63,331 - $113,636	2,731 New	2,731 $92,000
Q2 2020 Aug 11, 2020	SELL	$14.82 - $29.92 $10,210 - $20,614	-689 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $2,695 - $6,290	231 Added 50.44%	689 $11,000
Q4 2019 Feb 13, 2020	BUY	$16.92 - $28.96 $203 - $347	12 Added 2.69%	458 $11,000
Q3 2019 Oct 17, 2019	SELL	$20.0 - $31.88 $31,600 - $50,370	-1,580 Reduced 77.99%	446 $9,000
Q2 2019 Aug 05, 2019	BUY	$30.67 - $37.86 $55,206 - $68,148	1,800 Added 796.46%	2,026 $65,000
Q1 2019 Apr 16, 2019	BUY	$22.22 - $32.21 $777 - $1,127	35 Added 18.32%	226 $7,000
Q4 2018 Jan 17, 2019	BUY	$20.9 - $32.57 $3,991 - $6,220	191 New	191 $5,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.